7─羟基喹啉与甲醇、乙醇形成1：2桥式氢键化合物的AM1法研究

利用半经验ＡＭ１方法计算了基态与第一激发态７－羟基喹啉的两种异构体及其与甲醇等溶济分子形成１：２桥式氢键化合物的结构与稳定性。在基态，烯醇式结构比酮式结构稳定；而在第一激发态酮式比烯醇式稳定。１：２桥式氢键的形成使得酮式能量降低比烯醇式多。烯醇式１：２桥式氢键化合物呈交叉式结构，酮式１：２桥式氢键化合物呈折叠式结构，激发态的形成对氢键结构影响不大。在７－羟基喹啉羟基（或羰基）的邻位和间位引入取代基后，对喹啉环和桥式氢键结构的影响均不明显。     

7─羟基喹啉与甲醇、乙醇形成1：2桥式氢键化合物的AM1法研究

利用半经验ＡＭ１方法计算了基态与第一激发态７－羟基喹啉的两种异构体及其与甲醇等溶济分子形成１：２桥式氢键化合物的结构与稳定性。在基态，烯醇式结构比酮式结构稳定；而在第一激发态酮式比烯醇式稳定。１：２桥式氢键的形成使得酮式能量降低比烯醇式多。烯醇式１：２桥式氢键化合物呈交叉式结构，酮式１：２桥式氢键化合物呈折叠式结构，激发态的形成对氢键结构影响不大。在７－羟基喹啉羟基（或羰基）的邻位和间位引入取代基后，对喹啉环和桥式氢键结构的影响均不明显。     

Reactions of 2-Pyrones with 7-Aminoindazole: The First Synthesis of N-(1H-7-Indazolyl)-pyridinones

New N-(1H-7-indazolyl)-pyridinones have been prepared by the condensation of 2-pyrone derivatives with 7-aminoindazole in the presence of acid medium. They have been characterized by means of ¹H and ¹³C NMR, IR, and mass spectroscopy. The structure of the compounds and the mechanism of their formation are reported.     

Hydrogen-bonded complexes of 1-chloro-2-methylpropan-2-ol with ketones

The interaction of 1-choro-2-methylpropan-2-ol (CMP) with acetone and methyl ethyl ketone was examined in dilute carbon tetrachloride solution. The strengths of the hydrogen-bonded complexes were compared with those of the corresponding complexes of trimethyl carbinol and 1,1,1-trichloro-2-methyl-propan-2-ol with ketones. The aim was to explain the inductive effect of the chlorine atom on the strength of carbinol-ketone hydrogen-bonded complexes. The monomer IR band of CPM appears in solution as a composite of five sub-bands, signifying that many conformers are present; this was confimed by quantum chemical calculations. Chlorine substitution increases the strength of the hydrogen bond.     

Structural and photocatalytic properties of the new solid photocatalyst In2BiTaO7

In₂BiTaO₇ was synthesized using the solid-state reaction method and its photocatalytic properties were investigated. The results of powder X-ray diffraction (XRD) indicated that the compound crystallizes in the pyrochlore-type structure, cubic system with space group Fd-3m. The lattice parameter is 10.6972(1) ?. In addition, the compound shows strong optical absorption in the visible region (λ > 420 nm) and the band gap of In₂BiTaO₇ was estimated to be about 2.47 eV. For the photocatalytic reaction, H₂ or O₂ evolution was observed from CH₃OH/H₂O or AgNO₃ solution respectively with In₂BiTaO₇ as the photocatalyst under visible light irradiation, indicating that In₂BiTaO₇ is responsive to visible light for splitting water. Furthermore, the catalyst remained photoactive in the wavelength range up to 510 nm. Photocatalytic degradation of methylene blue (MB) dye over the compound was further investigated under visible light irradiation. The results showed that complete removal of aqueous MB could be achieved after irradiation for 135 min over In₂BiTaO₇. Furthermore, under visible light irradiation In₂BiTaO₇ showed markedly higher catalytic activity compared to P-25 for MB photocatalytic degradation.     

(Zn1-xMnx)C2O4·2H2O在空气中的热分解动力学研究

用热分析（TG-DTG/DTA）、X射线衍射（XRD）技术和透射电镜（TEM）研究了固态物质Zn_1-xMn_xC₂O₄•2H₂O在空气中热分解的过程。热分析结果表明，Zn_1-xMn_xC₂O₄•2H₂O在空气中分两步分解，其失重率与理论计算失重率相吻合。 XRD和TEM结果表明，Zn_1-xMn_xC₂O₄•2H₂O分解的最终产物为Zn_1-xMn_xO,其颗粒大小约为10-13 nm。在非等温条件下对Zn_1-xMn_xC₂O₄•2H₂O的热分解动力学进行了分析。用Friedman法和Flynn-Wall-Ozawa(FWO)法求取了分解过程的活化能E，并用多元线性回归给出了可能的机理函数。Zn_1-xMn_xC₂O₄•2H₂O两步热分解的活化能分别为155.7513 kJ/mol 和215.9397 kJ/mol。     

Pharmacophore Mapping Combined with dbCICA Reveal New Structural Features for the Development of Novel Ligands Targeting α4β2 and α7 Nicotinic Acetylcholine Receptors

The neuronal nicotinic acetylcholine receptors (nAChRs) belong to the ligand-gated ion channel (GLIC) group, presenting a crucial role in several biological processes and neuronal disorders. The α4β2 and α7 nAChRs are the most abundant in the central nervous system (CNS), being involved in challenging diseases such as epilepsy, Alzheimer’s disease, schizophrenia, and anxiety disorder, as well as alcohol and nicotine dependencies. In addition, in silico-based strategies may contribute to revealing new insights into drug design and virtual screening to find new drug candidates to treat CNS disorders. In this context, the pharmacophore maps were constructed and validated for the orthosteric sites of α4β2 and α7 nAChRs, through a docking-based Comparative Intermolecular Contacts Analysis (dbCICA). In this sense, bioactive ligands were retrieved from the literature for each receptor. A molecular docking protocol was developed for all ligands in both receptors by using GOLD software, considering GoldScore, ChemScore, ASP, and ChemPLP scoring functions. Output GOLD results were post-processed through dbCICA to identify critical contacts involved in protein-ligand interactions. Moreover, Crossminer software was used to construct a pharmacophoric map based on the most well-behaved ligands and negative contacts from the dbCICA model for each receptor. Both pharmacophore maps were validated by using a ROC curve. The results revealed important features for the ligands, such as the presence of hydrophobic regions, a planar ring, and hydrogen bond donor and acceptor atoms for α4β2. Parallelly, a non-planar ring region was identified for α7. These results can enable fragment-based drug design (FBDD) strategies, such as fragment growing, linking, and merging, allowing an increase in the activity of known fragments. Thus, our results can contribute to a further understanding of structural subunits presenting the potential for key ligand-receptor interactions, favoring the search in molecular databases and the design of novel ligands.     

Structural and impedance analysis of LiBiP2O7

A new material LiBiP₂O₇ was prepared by solid-state reaction method. The XRD analysis confirms the formation of the sample. The Raman analysis indicates the presence of characteristic bands for a (P₂O₇)⁴⁻ group in the sample. The electrical characterization was carried out using the impedance spectroscopy method in the frequency range of 1 KHz–5 MHz. The bulk conductivity of the material was extracted from the impedance analysis and was found to be in the order of 10⁻⁷ Ω ⁻¹ cm⁻¹ at 473 K. The activation energy was calculated from the Arrhenius plot and was found to be 0.37 eV. The modulus peak maximum shifts to higher frequencies with an increase in temperature and the broad nature of the peaks indicates the non-debye nature of the material. The high value for the activation energy calculated from the conductance spectrum indicates that some energy has been utilized in the creation of charge carriers.     

Structural Investigation of Hesperetin-7-O-Glucoside Inclusion Complex with β-Cyclodextrin: A Spectroscopic Assessment

Flavonoids are biologically active natural products of great interest for their potential applications in functional foods and pharmaceuticals. A hesperetin-7-O-glucoside inclusion complex with β-cyclodextrin (HEPT7G/βCD; SunActive^® HCD) was formulated via the controlled enzymatic hydrolysis of hesperidin with naringinase enzyme. The conversion rate was nearly 98%, estimated using high-performance liquid chromatography analysis. The objective of this study was to investigate the stability, solubility, and spectroscopic features of the HEPT7G/βCD inclusion complex using Fourier-transform infrared (FTIR), Raman, ultraviolet–visible absorption (UV–vis), ¹H- and ¹³C- nuclear magnetic resonance (NMR), differential scanning calorimetry (DSC), liquid chromatography/mass spectroscopy (LC–MS), scanning electron microscopy (SEM), and powdered X-ray diffraction (PXRD) spectroscopic techniques including zeta potential, Job’s plot, and phase solubility measurements. The effects of complexation on the profiles of supramolecular interactions in analytic features, especially the chemical shifts of β-CD protons in the presence of the HEPT7G moiety, were evaluated. The stoichiometric ratio, stability, and solubility constants (binding affinity) describe the extent of complexation of a soluble complex in 1:1 stoichiometry that exhibits a greater affinity and fits better into the β-CD inner cavity. The NMR spectroscopy results identified two different configurations of the HEPT7G moiety and revealed that the HEPT7G/βCD inclusion complex has both –2S and –2R stereoisomers of hesperetin-7-O-glucoside possibly in the –2S/–2R epimeric ratio of 1/1.43 (i.e., –2S: 41.1% and –2R: 58.9%). The study indicated that encapsulation of the HEPT7G moiety in β-CD is complete inclusion, wherein both ends of HEPT7G are included in the β-CD inner hydrophobic cavity. The results showed that the water solubility and thermal stability of HEPT7G were apparently increased in the inclusion complex with β-CD. This could potentially lead to increased bioavailability of HEPT7G and enhanced health benefits of this flavonoid.     

D936Y and Other Mutations in the Fusion Core of the SARS-CoV-2 Spike Protein Heptad Repeat 1: Frequency,Geographical Distribution,and Structural Effect

The crown of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is constituted by its spike (S) glycoprotein. S protein mediates the SARS-CoV-2 entry into the host cells. The “fusion core” of the heptad repeat 1 (HR1) on S plays a crucial role in the virus infectivity, as it is part of a key membrane fusion architecture. While SARS-CoV-2 was becoming a global threat, scientists have been accumulating data on the virus at an impressive pace, both in terms of genomic sequences and of three-dimensional structures. On 15 February 2021, from the SARS-CoV-2 genomic sequences in the GISAID resource, we collected 415,673 complete S protein sequences and identified all the mutations occurring in the HR1 fusion core. This is a 21-residue segment, which, in the post-fusion conformation of the protein, gives many strong interactions with the heptad repeat 2, bringing viral and cellular membranes in proximity for fusion. We investigated the frequency and structural effect of novel mutations accumulated over time in such a crucial region for the virus infectivity. Three mutations were quite frequent, occurring in over 0.1% of the total sequences. These were S929T, D936Y, and S949F, all in the N-terminal half of the HR1 fusion core segment and particularly spread in Europe and USA. The most frequent of them, D936Y, was present in 17% of sequences from Finland and 12% of sequences from Sweden. In the post-fusion conformation of the unmutated S protein, D936 is involved in an inter-monomer salt bridge with R1185. We investigated the effect of the D936Y mutation on the pre-fusion and post-fusion state of the protein by using molecular dynamics, showing how it especially affects the latter one.     

Design and Synthesis of 3,4-Dihydropyrrolo[2, 1-c][1, 4]oxazin-1-oneand its 7-Acyl Derivatives

Starting from 1H-pyrrole, unreported 3, 4-dihydropyrrolo[2, 1-c][l, 4]oxazin-1-one 4, 7-(4-chlorobenzoyl)-3, 4-dihydropyrrolo[2, 1-c][1, 4]oxazin-1-one 5 and 7-benzoyl-3, 4-dihydro-pyrrolo [2, 1-c][1, 4]oxazin-1-one 9 were designed and synthesized. They may have antipyretic and analgesic activities.     

2,6-二甲基-3-苯基-4a-对甲苯基-7-苯甲酰基-4a,5,6,12-四氢-1H,7H-1,3-噁嗪并[3,2-d][1,5]-苯并二氮杂-1-酮的合成及晶体结构

通过2-甲基-4-对甲苯基-1-苯甲酰基-2，3-二氢-1H－1，5-苯并二氮杂与由不对称1-苯基-2-偶氮-1，3-丁二酮热解产生的a-羰基烯酮的[2＋4]环加成反应制备了标题化合物（C34H30N2O3，Mr=514．62），用X射线衍射测定了其单晶结构。晶体属单斜晶系，空间群为P21／n，a=11．560（1），b=19．058（3），c=13．207（2）A，β=106.82（1）°，V=2785.2（7）A3，Z=4，Dc=1．230g．cm-3，MoKa（λ=0.71073A），μ=0．064mm-1，F（000）=1088，2278个可观测衍子射点，R=0．046，Rw=0．049。分子骨架为由苯环、具有类扭船式构象的七元二氮杂环和略微扭曲的唑酮环构成的三环体系。     

Synthesis of a New Ligand Containing 1,7—Diaza—12—crown—4 and the Application in Asymmetric Cyclopropanation Reaction

A new chiral multidenate ligand (S,S)-1,7-bis(4-benzyloxazolin-2-yl-methyl)-1,7-diaza-12-crown-4 1 has been synthesized and used as ligand in the copper catalyzed asymmetric cyclopropanation of 1,1-diphenylethylene.     

Design and synthesis of 2-alkylbenzimidazole derivatives as novel non-peptide angiotensin Ⅱ AT1 receptor antagonists

A series of 2-alkylbenzimidazole derivatives 9a-n have been designed and synthesized as a novel class of non-peptide angiotensin Ⅱ AT1 receptor antagonists. The synthesized compounds were evaluated for their antagonism of angiotensin Ⅱ, induced contraction in the rabbit thoracic aortic ring and the results showed that compounds 9a, 9g and 9j exhibited potent antagonistic activity of AT1 receptor.     

Synthesis and biological evaluation of substituted 2-anilino-7H-pyrrolopyrimidines as PDK1 inhibitors

An efficient and scalable route for a series of novel substituted 2-anilino-7H-pyrrolopyrimidine compounds as potential inhibitors of PDK1, an important regulator of the PI3K/Akt pathway that is dysregulated in many cancers, was developed and is described. The synthetic strategy was designed around Suzuki and Buchwald–Hartwig cross-couplings of a boronate fragment and various customised anilines sequentially with 2,4-dichloro-7-tosyl-7H-pyrrolopyrimidine. All fragments were constructed separately and cross-coupled to provide access to a range of novel compounds. Biological evaluation of these was undertaken, with modest inhibition observed.     

Unveiling the Role of DJ-1 Protein in Vesicular Storage and Release of Catecholamine with Nano/Micro-Tip Electrodes

DJ-1 protein deficiency caused by PARK7 gene mutation has been suggested to closely relate to Parkinson's disease (PD), mainly through the attenuation D2 dopamine receptor activity in mice; however, whether or how it affects the vesicular storage and exocytosis of neurochemicals remains unclear. By using electrochemical methods at a single vesicle/cell level with nano/micro-tip electrodes, we for the first time find that DJ-1 protein deficiency caused by PARK7 gene knockout (KO) in mice has little effect on vesicular catecholamine content but significantly prolongs the exocytotic events, especially the closing time of exocytotic fusion pores. Further studies suggest the inhibition of α-synuclein aggregation by DJ-1 protein might be one way that DJ-1 protein acts on neurotransmission. This finding offers the first direct link between DJ-1 protein deficiency and vesicular chemical storage and release of chemicals, providing a new chemical insight into the pathology of PD caused by PARK7 gene mutation.     

2-甲基-7-亚甲基-1,4,6-三氧螺[4,4]壬烷与丙烯腈、丙烯酸甲酯的共聚合反应及竞聚率的测定

用高效液相色谱跟踪2-甲基-7-亚甲基-1,4,6-三氧螺[4,4]壬烷(MMTN)与丙烯腈(AN),丙烯酸甲酯(MA)的共聚合反应。根据Lowry-Meyer共聚积分方程式,采用插值法进行数据拟合测定单体的竞聚率。对于体系MMTN(M_1)-AN(M_2),r_1=0.048;r_2=0.213;MMTN(M_1)-MA(M_2)r_1=0.025,r_2=0.764。说明两组共聚体系均有较强的交替共聚趋势。     

铟(Ⅲ)-7-(1-苯偶氮)-8-羟基喹啉-5-磺酸钠的配位吸附波及其应用

在ｐＨ４．５的 ０．０１５ ｍｏｌ／Ｌ ＨＡｃ－ＮａＡｃ介质中，Ｉｎ铟（Ⅲ）－７－（１－苯偶氮）－８－羟基喹啉－５－磺酸钠（ＢＱ）在滴汞电极上于－０．６６５－０．７０ Ｖ（ｖｓ．ＳＣＥ）电位处得到络合物的吸附还原波，其一阶导数峰电流Ｉ＇ｐ与Ｉｎ（Ⅲ）浓度在４．０× １０~（－８）～３．５ × １０~（－６）ｍｏｌ／Ｌ范围内呈良好的线性关系，检测限为１．６ × １０~（－８）ｍｏｌ／Ｌ Ｉｎ（Ⅲ）．应用该法测定了铅粉和氢氧化铝样品中的微量铟，结果令人满意。对电极反应机理进行了探讨。     

钼(Ⅵ)-7-(1-苯偶氮)-8-羟基喹啉-5-磺酸钠络合吸附波研究及应用

在pH4.8的0.013mol/L的HAc-NaAc介质中,钥(Ⅵ)-7-(1-苯偶氮)-8-羟基喹啉-5-磺酸钠体系在滴汞电极上,于-0.46V(vs.SCE)电位处得到良好的吸附还原波,其二阶导数峰电流I_p与Mo(Ⅵ)在2.5×10~(-8)～4.5×10~(-7)mol/L浓度范围内呈良好的线性关系,检测限为1.25×10~(-8)mol/L Mo(Ⅵ),方法用于钢样中微量钼的测定,结果较好.对电极机理进行了研究.     

七元瓜环对2'-羟基查尔酮溶解性、稳定性及抗氧化活性的影响

利用~1H NMR、紫外吸收光谱和荧光光谱等方法考察了七元瓜环(Q[7])对2'-羟基查尔酮(CET)的包结作用.结果表明,Q[7]与CET形成了摩尔比为1∶1的包结配合物,紫外吸收光谱和荧光光谱测得的结合稳定常数分别为1.0248×10~6和1.253×10~6.相溶解度法研究结果表明,当Q[7]的浓度为1×10~(-3)mol/L时,可使CET在水中的溶解度增加52倍.紫外吸收光谱随时间变化的研究结果表明,Q[7]使CET的稳定性增加3.5倍.采用体外抗氧化活性测定(ABTS法)考察了Q[7]对CET抗氧化活性的影响,发现CET@Q[7]包结配合物以及游离CET均对ABTS自由基有较好的清除作用.IC50值分别为3.4×10~(-5)和2.4×10~(-5)mol/L,表明Q[7]不仅能增加CET的溶解性和稳定性,同时对CET抗氧化活性的影响不大.